Profile | GDS4284 / 236528_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2677.89 | 87 |
GSM687648 | Patient 402 control | 3262.63 | 89 |
GSM687653 | Patient 403 control | 2477.13 | 86 |
GSM687658 | Patient 404 control | 3757.3 | 91 |
GSM687663 | Patient 411 control | 3917.55 | 91 |
GSM687668 | Patient 422 control | 6673.55 | 95 |
GSM687673 | Patient 424 control | 2207.56 | 85 |
GSM687678 | Patient 425 control | 5272.42 | 94 |
GSM687683 | Patient 427 control | 4248.53 | 92 |
GSM687688 | Patient 428 control | 4006.3 | 92 |
GSM687695 | Patient 441 control | 2437.31 | 87 |
GSM687699 | Patient 443 control | 5210.27 | 94 |
GSM687704 | Patient 444 control | 4295.77 | 92 |
GSM687707 | Patient 448 control | 5874.54 | 94 |
GSM687712 | Patient 449 control | 4295.1 | 92 |
GSM687719 | Patient 450 control | 2910.22 | 89 |
GSM687724 | Patient 451 control | 4196.57 | 92 |
GSM687728 | Patient 452 control | 5866.2 | 94 |
GSM687646 | Patient 401 treated 24h | 3216.38 | 89 |
GSM687649 | Patient 402 treated 24h | 3691.51 | 91 |
GSM687665 | Patient 411 treated 24h | 3912.16 | 91 |
GSM687651 | Patient 402 treated 4 weeks | 3638.11 | 91 |
GSM687667 | Patient 411 treated 4 weeks | 3319.43 | 90 |
GSM687670 | Patient 422 treated 24h | 6878.23 | 95 |
GSM687671 | Patient 422 treated 4 weeks | 5617.6 | 94 |
GSM687654 | Patient 403 treated 24h | 2438.7 | 86 |
GSM687675 | Patient 424 treated 24h | 1897.15 | 83 |
GSM687685 | Patient 427 treated 24h | 4680.15 | 93 |
GSM687656 | Patient 403 treated 4 weeks | 3097.57 | 89 |
GSM687677 | Patient 424 treated 4 weeks | 3454.24 | 90 |
GSM687687 | Patient 427 treated 4 weeks | 3619.16 | 90 |
GSM687692 | Patient 428 treated 4h | 3613.78 | 90 |
GSM687716 | Patient 449 treated 4h | 4175 | 92 |
GSM687722 | Patient 450 treated 4h | 2967.04 | 89 |
GSM687680 | Patient 425 treated 24h | 4866.87 | 93 |
GSM687690 | Patient 428 treated 24h | 3693.77 | 91 |
GSM687700 | Patient 443 treated 24h | 3934.59 | 92 |
GSM687705 | Patient 444 treated 24h | 3746.68 | 91 |
GSM687714 | Patient 449 treated 24h | 3785.08 | 91 |
GSM687721 | Patient 450 treated 24h | 2307.81 | 86 |
GSM687682 | Patient 425 treated 4 weeks | 6252.34 | 95 |
GSM687694 | Patient 428 treated 4 weeks | 3581.66 | 90 |
GSM687702 | Patient 443 treated 4 weeks | 3234.1 | 90 |
GSM687718 | Patient 449 treated 4 weeks | 3600.78 | 91 |
GSM687723 | Patient 450 treated 4 weeks | 2553.89 | 87 |
GSM687661 | Patient 404 treated 4h | 3780.69 | 91 |
GSM687710 | Patient 448 treated 4h | 5923.11 | 94 |
GSM687726 | Patient 451 treated 4h | 4273.35 | 92 |
GSM687730 | Patient 452 treated 4h | 1782.59 | 84 |
GSM687660 | Patient 404 treated 24h | 5068.38 | 93 |
GSM687697 | Patient 441 treated 24h | 2406.84 | 87 |
GSM687709 | Patient 448 treated 24h | 4747.64 | 93 |
GSM687725 | Patient 451 treated 24h | 3306.87 | 90 |
GSM687729 | Patient 452 treated 24h | 5628.39 | 94 |
GSM687727 | Patient 451 treated 4 weeks | 6473.11 | 95 |
GSM687731 | Patient 452 treated 4 weeks | 4697.18 | 93 |